# Gadobutrol Magnevist-controlled Body Study

> **NCT01050829** · PHASE3 · COMPLETED · sponsor: **Bayer** · enrollment: 370 (actual)

## Conditions studied

- Magnetic Resonance Imaging

## Interventions

- **DRUG:** Gadobutrol (Gadovist, BAY86-4875)
- **DRUG:** Gadopentetate Dimeglumine (Magnevist, BAY86-4882)

## Key facts

- **NCT ID:** NCT01050829
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 370 (ACTUAL)
- **Last updated:** 2014-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01050829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01050829, "Gadobutrol Magnevist-controlled Body Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01050829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*